Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antifungal chemotherapy in patients with acquired immunodeficiency syndrome. British Society for Antimicrobial Chemotherapy Working Party.

× No keyword cloud information.

12 in total

Review 1. Liposomal amphotericin B. Therapeutic use in the management of fungal infections and visceral leishmaniasis.

Authors: A J Coukell; R N Brogden
Journal: Drugs Date: 1998-04 Impact factor: 9.546

Review 2. Azole resistance in Candida.

Authors: D W Denning; G G Baily; S V Hood
Journal: Eur J Clin Microbiol Infect Dis Date: 1997-04 Impact factor: 3.267

3. Clinical and mycological evaluation of fluconazole in the secondary prophylaxis of esophageal candidiasis in AIDS patients. An open, multicenter study.

Authors: M G Agresti; F de Bernardis; F Mondello; R Bellocco; G P Carosi; R M Caputo; F Milazzo; F Chiodo; V Giannini; L Minoli
Journal: Eur J Epidemiol Date: 1994-02 Impact factor: 8.082

4. Influence of concomitant food intake on the oral absorption of two triazole antifungal agents, itraconazole and fluconazole.

Authors: T Zimmermann; R A Yeates; H Laufen; G Pfaff; A Wildfeuer
Journal: Eur J Clin Pharmacol Date: 1994 Impact factor: 2.953

5. Correlation between in vitro susceptibility of Candida albicans and fluconazole-resistant oropharyngeal candidiasis in HIV-infected patients.

Authors: N Troillet; C Durussel; J Bille; M P Glauser; J P Chave
Journal: Eur J Clin Microbiol Infect Dis Date: 1993-12 Impact factor: 3.267

6. Management of deep Candida infection in surgical and intensive care unit patients. British Society for Antimicrobial Chemotherapy Working Party.

Authors:
Journal: Intensive Care Med Date: 1994-08 Impact factor: 17.440

Review 7. Fluconazole. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic use in major superficial and systemic mycoses in immunocompromised patients.

Authors: K L Goa; L B Barradell
Journal: Drugs Date: 1995-10 Impact factor: 9.546

8. Treatment of oropharyngeal candidiasis in HIV-infected children with oral fluconazole. Multicentre Study Group [corrected].

Authors: P Marchisio; N Principi
Journal: Eur J Clin Microbiol Infect Dis Date: 1994-04 Impact factor: 3.267

9. Ketoconazole in atopic dermatitis: therapeutic response is correlated with decrease in serum IgE.

Authors: O Bäck; A Scheynius; S G Johansson
Journal: Arch Dermatol Res Date: 1995 Impact factor: 3.017

10. Treating progressive disseminated histoplasmosis in people living with HIV.

Authors: Marylou Murray; Paul Hine
Journal: Cochrane Database Syst Rev Date: 2020-04-28